mICRA statement of endorsement
Model Industry Collaborative Research Agreement (mICRA) Statement of Endorsement
We endorse the development of the model Industry Collaborative Research Agreement (mICRA) and commend its routine use for research collaborations involving industry, universities and the NHS.
As members of the working group developing a model agreement for industry collaborative research we participated in a rigorous process involving representatives and legal advisors of the key stakeholders in commercial clinical research.
This process resulted in agreement on the terms of a range of model agreements to support clinical research collaborations involving the pharmaceutical and biotechnology industries, academia and NHS organisations.
These agreement templates should make a major contribution to improving the speed, ease and efficiency of negotiating the terms under which individual collaborations are conducted and therefore help to ensure that the initiation of collaborative studies in the UK is not subject to unnecessary delay.
We therefore commend its routine use by all parties involved in industry collaborative research.
23 February 2011
mICRA working group members included:
Association of Medical Research Charities
Association of the British Pharmaceutical Industry
Association of UK University Hospitals
Chief Scientist Office, Scotland
Department for Business, Innovation & Skills
Department of Health
Intellectual Property Office
Medical Research Council
Medical Schools Council
National Institute for Health Research
National Institute for Social Care and Health Research, Welsh Assembly Government
NHS Research Scotland
Northern Ireland Health and Social Care Research & Development